A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection

Author:

Malherbe Delphine C.,Domi Arban,Hauser Mary J.,Atyeo Caroline,Fischinger Stephanie,Hyde Matthew A.,Williams Julie M.,Alter GalitORCID,Guirakhoo Farshad,Bukreyev AlexanderORCID

Abstract

AbstractA new vectored vaccine MVA-VLP-SUDV was generated against Sudan ebolavirus (SUDV) combining the advantages of the immunogenicity of a live attenuated vaccine vector (Modified Vaccinia Ankara, MVA) with the authentic conformation of virus-like particles (VLPs). The vaccine expresses minimal components to generate self-assembling VLPs in the vaccinee: the envelope glycoprotein GP and the matrix protein VP40. Guinea pigs vaccinated with one dose of MVA-VLP-SUDV generated SUDV-specific binding and neutralizing antibody responses as well as Fc-mediated protective effects. These responses were boosted by a second vaccine dose. All vaccinated animals which received either one or two vaccine doses were protected from death and disease symptoms following challenge with a lethal dose of SUDV. These data demonstrate single dose protection and potency of the MVA-VLP platform for use in emergency situations to contain outbreaks.

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology

Reference27 articles.

1. Kuhn, J. H., Amarasinghe, G. K. & Perry, D. L. Filoviridae: Marburg and Ebola Viruses. 7 edn, Vol. 1 449–503 (Lippincott-Raven Publishers, 2021).

2. FDA. ERVEBO. https://www.fda.gov/vaccines-blood-biologics/ervebo (2020).

3. Agency, E. M. New vaccine for prevention of Ebola virus disease recommended for approval in the European Union, https://www.ema.europa.eu/en/news/new-vaccine-prevention-ebola-virus-disease-recommended-approval-european-union (2020).

4. Herbert, A. S. et al. Development of an antibody cocktail for treatment of Sudan virus infection. Proc. Natl Acad. Sci. USA 117, 3768–3778 (2020).

5. Wolfe, D. N., Taylor, M. J. & Zarrabian, A. G. Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus. Hum. Vaccin Immunother. 16, 2855–2860 (2020).

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3